Lack of association between Tenascin-C gene and spondyloarthritis

Rheumatology

Volumn 47, Issue 11, 2008, Pages 1655-1658

  Zinovieva, E ^a   Lebrun, N ^a   Letourneur, F ^a   Laurent, F X ^a   Said Nahal, R ^b   Chiocchia, G ^a   Breban, Maxime ^a,b,c  

^a INSTITUT COCHIN   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Ankylosing spondylitis; Association study; Genetics; Spondyloarthritis; Tenascin C

Indexed keywords

TENASCIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLARTHRITIS; TENASCIN;

EID: 54449096933     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken378     Document Type: Article

References (20)

1. Saraux A, Guillemin F, Guggenbuhl P et al. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005;64:1431-5.
2. Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R. The genetics of spondyloarthropathies. Joint Bone Spine 2006;73:355-62.
3. Said-Nahal R, Miceli-Richard C, Berthelot J-M et al. The familial form of spondylarthropathy: A clinical study of 115 multiplex families. Arthritis Rheum 2000;43:1356-65.
4. Dernis E, Said-Nahal R, D'Agostino MA, Aegerter P, Dougados M, Breban M. Recurrence of spondylarthropathy among first-degree relatives of patients, a systematic cross-sectional study. Ann Rheum Dis. Advance access published April 15, 2008, doi: 10.1136/ard.2008.089599.
5. Miceli-Richard C, Zouali H, Said-Nahal R et al. Significant linkage to spondyloarthropathy on 9q31-34. Hum Mol Genet 2004;13:1641-8.
6. Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
7. de Palma L, Marinelli M, Meme L, Pavan M. Immunohistochemistry of the enthesis organ of the human Achilles tendon. Foot Ankle Int 2004;25:414-8.
8. Mokone GG, Gajjar M, September AV et al. The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016-21.
9. Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 1990;57:85-9.
10. Dougados M, van der Linden S, Juhlin R et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
11. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
12. Willkens RF, Arnett FC, Bitter T et al. Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981;24:844-9.
13. Chiquet-Ehrismann R, Chiquet M. Tenascins: Regulation and putative functions during pathological stress. J Pathol 2003;200:488-99.
14. Jarvinen TA, Jozsa L, Kannus P et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 2003; 116:857-66.
15. Hasegawa M, Nakoshi Y, Muraki M et al. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res 2007;25:563-8.
16. Gerritsen MJ, Elbers ME, de Jong EM, van de Kerkhof PC. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci 1997;14:179-88.
17. Riedl S, Tandara A, Reinshagen M et al. Serum tenascin-C is an indicator of inflammatory bowel disease activity. Int J Colorectal Dis 2001;16:285-91.
18. Breban M, Hacquard-Bouder C, Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 2004;4:21-40.
19. Kuznetsova SA, Roberts DD. Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int J Biochem Cell Biol 2004;36:1126-34.
20. Sims AM, Barnardo M, Herzberg I et al. Non-B27 MHC associations of ankylosing spondylitis. Genes Immun 2007;8:115-23.